Key Record Dates Identifier: NCT00427362
Brief Title: A Canadian Open-Label Study to Evaluate the Safety and Effectiveness of Adalimumab When Added to Inadequate Therapy for the Treatment of Psoriatic Arthritis (PsA) (ACCLAIM)

First Submitted : January 26, 2007
First Submitted that Met QC Criteria : January 26, 2007
First Posted : January 29, 2007 (Estimate)

Last Update Submitted that Met QC Criteria : April 30, 2008
Last Update Posted : May 2, 2008 (Estimate)